PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES AS CARRIER OF ANTI-ALZHEIMER TACRINE DRUG AND SIZE ESTIMATION OF NANOPARTICLES BY CHEMOMETRICS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

KHANMOHAMMADI M.; ELMIZADEH H.; HASSANZADEH G.; NASSIRI ASL M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Inflammatory Diseases Year:2014 | Volume:17 | Issue:5 (70) Page(s): 10-16

Download Full-Text

Persian Verion

View:

1,561

Download:

Cites:

Information Journal Paper

Title

PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES AS CARRIER OF ANTI-ALZHEIMER TACRINE DRUG AND SIZE ESTIMATION OF NANOPARTICLES BY CHEMOMETRICS

Author(s)

KHANMOHAMMADI M. | ELMIZADEH H. | HASSANZADEH G. | NASSIRI ASL M. | Issue Writer Certificate

Keywords

NANOPARTICLESQ1

TACRINEQ2

DRUG DELIVERY SYSTEMSQ2

ALZHEIMER DISEASEQ2

Abstract

Background: DRUG DELIVERY SYSTEMS were developed to improve the efficiency of drugs and minimize toxic side effects during the 1980s and 1990s. NANOPARTICLES have the ability to deliver a wide range of drugs to different areas of the body for sustained periods of time.Objective: The aim of this study was to prepare and optimize chitosan NANOPARTICLES as carrier of anti-alzheimer TACRINE drug and to estimate particle size by chemometrics.Methods: This experimental study was conducted at chemistry school of Imam Khomeini International University in Qazvin during 2011-2012. Chitosan NANOPARTICLES were prepared by spontaneous emulsification method. In order to optimize the method of chitosan NANOPARTICLES preparation, Design of Experiment (DOE) was employed using Box-Behnken design. Also, chitosan NANOPARTICLES containing TACRINE were prepared using the optimal synthesis method provided by the experimental design. The relationship between particle size and Diffuse Reflectance Infrared Fourier Transform (DRIFT) Spectroscopy was employed to introduce a method for estimation of particle size in chitosan NANOPARTICLES. Partial least squares (PLS) technique was applied to estimate average particle size based on DRIFT spectra. Forty two chitosan NANOPARTICLES samples with different particle size were analyzed by DRIFT spectrometry and the data were processed by PLSNAS. Size and morphology of NANOPARTICLES were determined by field emission scanning electron microscopy (FE-SEM).Findings: According to Box–Behnken experimental design results, 0.52% NaCl as an electrolyte, 10% Span 80 as a surfactant and 4.86 mL Glutaraldehyde Saturated Toluene (GST) as a chemical cross-linking agent are optimum amounts to prepare the lowest size and spherical morphology of NANOPARTICLES. The mean particle size of the designed NANOPARTICLES was 33.64 to 74.87 nm. Percent yield and drug loading percent of chitosan NANOPARTICLES that were synthesized according to the optimal method were 90% and 13.4±0.51%, respectively. The estimated sizes of chitosan NANOPARTICLES give promise to a robust and reliable calibration that were confirmed with a correlation coefficient (R2) of 0.98 and a Root Mean Square Error (RMSE) of 3.59.Conclusion: With regards to the results, an optimized method for the preparation of chitosan NANOPARTICLES as carrier of anti-alzheimer drug can be presented with smaller particle size and spherical morphology using Box-Behnken experimental design.

Cites

No record.

References

No record.

Cite

APA: Copy

KHANMOHAMMADI, M., ELMIZADEH, H., HASSANZADEH, G., & NASSIRI ASL, M.. (2014). PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES AS CARRIER OF ANTI-ALZHEIMER TACRINE DRUG AND SIZE ESTIMATION OF NANOPARTICLES BY CHEMOMETRICS. JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES), 17(5 (70)), 10-16. SID. https://sid.ir/paper/49301/en

Vancouver: Copy

KHANMOHAMMADI M., ELMIZADEH H., HASSANZADEH G., NASSIRI ASL M.. PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES AS CARRIER OF ANTI-ALZHEIMER TACRINE DRUG AND SIZE ESTIMATION OF NANOPARTICLES BY CHEMOMETRICS. JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES)[Internet]. 2014;17(5 (70)):10-16. Available from: https://sid.ir/paper/49301/en

IEEE: Copy

M. KHANMOHAMMADI, H. ELMIZADEH, G. HASSANZADEH, and M. NASSIRI ASL, “PREPARATION AND OPTIMIZATION OF CHITOSAN NANOPARTICLES AS CARRIER OF ANTI-ALZHEIMER TACRINE DRUG AND SIZE ESTIMATION OF NANOPARTICLES BY CHEMOMETRICS,” JOURNAL OF INFLAMMATORY DISEASES (THE JOURNAL OF QAZVIN UNIVERSITY OF MEDICAL SCIENCES), vol. 17, no. 5 (70), pp. 10–16, 2014, [Online]. Available: https://sid.ir/paper/49301/en

Related Journal Papers